Claybrook Capital’s Abbott ABT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-1,600
Closed -$225K 130
2021
Q4
$225K Buy
+1,600
New +$205K 0.11% 128
2021
Q3
Sell
-34,959
Closed -$4.05M 127
2021
Q2
$4.05M Buy
+34,959
New +$4.08M 1.32% 18
2019
Q1
Sell
-58,549
Closed -$4.24M 95
2018
Q4
$4.24M Buy
58,549
+56,949
+3,559% +$4M 1.19% 17
2018
Q3
$117K Hold
1,600
0.07% 90
2018
Q2
$98K Hold
1,600
0.06% 91
2018
Q1
$96K Buy
1,600
+400
+33% +$24.1K 0.06% 89
2017
Q4
$68K Buy
+1,200
New +$66.5K 0.05% 112

Other funds holding ABT

Claybrook Capital's ABT Position: Q1 2022 in Review

Claybrook Capital sold out of Abbott (ABT) in Q1 2022, closing a stake of 1,600 shares — an estimated $225K sold.

Claybrook Capital first reported a position in ABT in Q4 2017 and held it in 7 quarters. The position peaked at $4.24M in Q4 2018. 2,760 funds tracked by Wall St. Rank hold ABT as of Q1 2022.

  • Claybrook Capital reported no remaining Abbott position as of Q1 2022 after selling out during the quarter.
  • Claybrook Capital sold 1,600 Abbott shares in Q1 2022, an estimated $225K.
  • Claybrook Capital first reported a position in Abbott in Q4 2017 and held it in 7 quarters.
  • Claybrook Capital's Abbott position peaked at $4.24M in Q4 2018.
  • 2,760 funds tracked by Wall St. Rank held Abbott as of Q1 2022.

Based on Claybrook Capital's 13F filing for Q1 2022, filed 6 May 2022.